{"id":"NCT01954394","sponsor":"Sanofi","briefTitle":"Open Label Study of Long Term Safety Evaluation of Alirocumab","officialTitle":"Open-Label Extension Study of EFC12492, R727-CL-1112, EFC12732 and LTS11717 Studies to Assess the Long-Term Safety and Efficacy of Alirocumab in Patients With Heterozygous Familial Hypercholesterolemia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-12-17","primaryCompletion":"2017-06-30","completion":"2017-06-30","firstPosted":"2013-10-01","resultsPosted":"2018-07-24","lastUpdate":"2018-07-24"},"enrollment":986,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hypercholesterolemia"],"interventions":[{"type":"DRUG","name":"Alirocumab","otherNames":["SAR236553","REGN727","Praluent"]},{"type":"DRUG","name":"Lipid-Modifying Therapy (LMT)","otherNames":[]}],"arms":[{"label":"Alirocumab 75 or 150 mg Q2W","type":"EXPERIMENTAL"}],"summary":"Primary Objective:\n\nTo assess the long-term safety of alirocumab (SAR236553/REGN727) when added to lipid-lowering therapy in participants with heterozygous familial hypercholesterolemia (heFH) who had completed EFC12492 (NCT01623115), R727-CL-1112 (NCT01709500), EFC12732 (NCT01617655) and LTS11717 (NCT01507831).\n\nSecondary Objectives:\n\n* To evaluate the long-term efficacy of alirocumab on lipid parameters.\n* To evaluate the long-term immunogenicity of alirocumab.","primaryOutcome":{"measure":"Percentage of Participants Who Experienced Adverse Events (AEs)","timeFrame":"Up to 10 weeks after last study drug administration (maximum of 176 weeks)","effectByArm":[{"arm":"Placebo to Alirocumab 75 or 150 mg Q2W","deltaMin":83.9,"sd":null},{"arm":"Alirocumab to Alirocumab 75 or 150 mg Q2W","deltaMin":87.3,"sd":null},{"arm":"Alirocumab: All Participants","deltaMin":86.2,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":177,"countries":["United States","Argentina","Austria","Belgium","Bulgaria","Canada","Czechia","Denmark","Finland","France","Germany","Hungary","Israel","Italy","Mexico","Netherlands","Norway","Portugal","Romania","Russia","South Africa","Spain","Sweden","United Kingdom"]},"refs":{"pmids":["30591415","30293878","30287210"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":68,"n":330},"commonTop":["Viral upper respiratory tract infection","Upper respiratory tract infection","Influenza","Arthralgia","Back pain"]}}